Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2600 (104th)

To provide for coverage of certain anti-cancer drug treatments under Medicare.

referredUnited States· United States Congress· EN

Introduced

8 November 1995

Last action

20 November 1995 · Referred

Status

Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.

Sponsors

Rep. Obey, David R. [D-WI-7], Rep. Beilenson, Anthony C. [D-CA-24], Rep. Farr, Sam [D-CA-20], Rep. Skaggs, David E. [D-CO-2], Rep. Kildee, Dale E. [D-MI-5], Rep. Thurman, Karen L. [D-FL-5], Rep. Levin, Sander M. [D-MI-12], Rep. Gilman, Benjamin A. [R-NY-20], Rep. Waxman, Henry A. [D-CA-33], Rep. Kennelly, Barbara B. [D-CT-1], Rep. Williams, Pat [D-MT-At Large], Rep. Murtha, John P. [D-PA-12], Rep. Hoyer, Steny H. [D-MD-5], Rep. Pelosi, Nancy [D-CA-11], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Bonior, David E. [D-MI-10], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Barrett, Thomas M. [D-WI-5], Rep. Waters, Maxine [D-CA-43], Rep. Clayton, Eva M. [D-NC-1], Rep. Lowey, Nita M. [D-NY-17]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Amends title XVIII (Medicare) of the Social Security Act to extend Medicare part A (Hospital Insurance) coverage to any Food and Drug Administration-approved oral drug prescribed as an anticancer nonsteroidal antiestrogen or nonsteroidal antiandrogen agent for a given indication. Provides for uniform coverage of such drugs in all settings.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 8 November 1995

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 8 November 1995

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 8 November 1995

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 8 November 1995

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 13 November 1995

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 20 November 1995

    Referred

    Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 8 November 1995

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 8 November 1995

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 8 November 1995

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.